The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity.

[1]  W. Hazzard,et al.  A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. , 1991, Metabolism: clinical and experimental.

[2]  B. Guy-grand,et al.  Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic. , 1991, Fertility and sterility.

[3]  K. Feingold,et al.  Testosterone regulates metabolism of plasma chylomicrons in rats. , 1990, Arteriosclerosis.

[4]  Robert E. Jones,et al.  High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. , 1990, Metabolism: clinical and experimental.

[5]  W. Hazzard,et al.  Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. , 1989, Journal of lipid research.

[6]  P. Thompson,et al.  Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. , 1989, JAMA.

[7]  J. Brunzell,et al.  Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. , 1988, The Journal of clinical investigation.

[8]  P. Thompson,et al.  Elevated high-density lipoprotein cholesterol in endurance athletes is related to enhanced plasma triglyceride clearance. , 1988, Metabolism: clinical and experimental.

[9]  P. Nilsson-ehle,et al.  Increase in hepatic lipase activity after testosterone substitution in men with hypogonadism of pituitary origin. , 2009, Acta medica Scandinavica.

[10]  W. Hazzard,et al.  The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol. , 1987, Metabolism: clinical and experimental.

[11]  E. Nikkilä,et al.  Regulation of hepatic lipase and serum lipoproteins by sex steroids. , 1987, American heart journal.

[12]  D. Catlin,et al.  Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984. , 1987, Clinical chemistry.

[13]  P. Thompson,et al.  Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity. , 1985, Medicine and science in sports and exercise.

[14]  M. Alen,et al.  Response of serum hormones to androgen administration in power athletes. , 1985, Medicine and science in sports and exercise.

[15]  G. Getz,et al.  Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. , 1985, The Journal of clinical endocrinology and metabolism.

[16]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[17]  H. Brewer,et al.  The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. , 1983, The Journal of clinical endocrinology and metabolism.

[18]  S. Haffner,et al.  Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. , 1983, Metabolism: clinical and experimental.

[19]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[20]  E. Nikkilä,et al.  High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. , 1982, The Journal of clinical endocrinology and metabolism.

[21]  G. Wade,et al.  Cytoplasmic estrogen, but not progestin, binding sites in male rat adipose tissues. , 1980, The American journal of physiology.

[22]  P. Nilsson-ehle,et al.  Lipolytic enzymes and plasma lipoprotein metabolism. , 1980, Annual review of biochemistry.

[23]  J. Wilson,et al.  Origin of estrogen in normal men and in women with testicular feminization. , 1979, The Journal of clinical endocrinology and metabolism.

[24]  A S Jackson,et al.  Generalized equations for predicting body density of men , 1978, British Journal of Nutrition.

[25]  D. Fredrickson,et al.  Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease. , 1978, Metabolism: clinical and experimental.

[26]  J. Albers,et al.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. , 1978, Journal of lipid research.

[27]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[28]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[29]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[30]  K. Horký,et al.  Effect of aminoglutethimide on extraglandular metabolism of exogenous testosterone. , 1971, Metabolism: clinical and experimental.

[31]  G. Gordan,et al.  High‐dosage Δ1‐testololactone therapy of disseminated carcinoma of the breast , 1967 .

[32]  R. P. Howard,et al.  Metabolic and Serum Lipid Effects of Δ1-Testololactone.∗ , 1962 .